Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4 Registration of securities issued in business combination transactions
- 3.1 Exhibit 3.1
- 3.3 Exhibit 3.3
- 23.4 Exhibit 23.4
- 23.5 Exhibit 23.5
- 99.2 Exhibit 99.2
- 99.4 Exhibit 99.4
- 99.6 Exhibit 99.6
- 99.7 Exhibit 99.7
- 99.8 Exhibit 99.8
- 99.9 Exhibit 99.9
- 99.10 Exhibit 99.10
- 99.11 Exhibit 99.11
- 99.12 Exhibit 99.12
- 99.13 Exhibit 99.13
- 99.14 Exhibit 99.14
- 99.15 Exhibit 99.15
- 99.16 Exhibit 99.16
- 99.17 Exhibit 99.17
- 99.18 Exhibit 99.18
- 99.19 Exhibit 99.19
CI similar filings
- 12 Jul 18 Registration of securities issued in business combination transactions (amended)
- 9 Jul 18 Registration of securities issued in business combination transactions (amended)
- 20 Jun 18 Registration of securities issued in business combination transactions (amended)
- 16 May 18 Registration of securities issued in business combination transactions
Filing view
External links
Exhibit 99.11
RULE 438 CONSENT OF PROSPECTIVE DIRECTOR
In accordance with Rule 438 promulgated under the Securities Act of 1933, as amended, I hereby consent to my being named in the Registration Statement on Form S-4, to which this consent is an exhibit, filed by Halfmoon Parent, Inc. (“New Cigna”) with the Securities and Exchange Commission, and all amendments (including post-effective amendments) thereto (the “Registration Statement”) and any prospectus and/or proxy statement contained therein and any amendment or supplement thereto, as a person who is to become a director of Holdco, effective at the Effective Time (as such term is defined in the Agreement and Plan of Merger, dated as of March 8, 2018 (the “Merger Agreement”), by and among Cigna Corporation, Express Scripts Holding Company, New Cigna, Halfmoon I, Inc. and Halfmoon II, Inc.) and to the filing of this consent as an exhibit to the Registration Statement.
| /s/ John M. Partridge | |
| John M. Partridge | |
| May 15, 2018 |